Zika and Neurodevelopment Among Infants in Grenada
Rescuing Neurodevelopment in Zika-Exposed Infants in Grenada
1 other identifier
interventional
148
1 country
1
Brief Summary
Implement a randomized controlled trial, evidence-based, culturally adapted, environmental enrichment intervention for the purpose of enhancing neurocognitive outcomes among Zika Exposed Children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 22, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2020
CompletedFirst Submitted
Initial submission to the registry
January 4, 2021
CompletedFirst Posted
Study publicly available on registry
January 6, 2021
CompletedJanuary 7, 2021
January 1, 2021
1.5 years
January 4, 2021
January 5, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
The INTERGROWTH 21st Neurodevelopmental Assessment (INTER-NDA)
The INTER-NDA is a measure of cognition, motor skills (fine and gross motor), language (expressive and receptive), behavior, executive function, attention and social-emotional reactivity for 2-year-olds. The measure is comprised of 30 items scored across a spectrum, with higher scores indicating better outcomes.
22-30 months
Study Arms (2)
Intervention Group
EXPERIMENTALImmediately randomized to receive the intervention for 12 weeks.
Waitlist Control
NO INTERVENTIONRandomized to receive the intervention post-study.
Interventions
Conscious Discipline, a social-emotional skills-based learning program that draws on current brain research and fosters enhanced connections between parents and their children.
Eligibility Criteria
You may qualify if:
- Must be actively enrolled in the pre-existing Zika Cohort Study
- Infant must be alive and living with a parent/guardian at the time of recruitment
- Infant must be between 24-27 months at the time of recruitment
You may not qualify if:
- Any infants older than 27 months
- Persons not enrolled in the pre-existing Zika Cohort Study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Windward Islands Research and Education Foundationlead
- St. George's Universitycollaborator
- Stanford Universitycollaborator
- National Institutes of Health (NIH)collaborator
Study Sites (1)
Windward Islands Research and Education Foundation (WINDREF)
Saint George's, Grenada
Related Publications (1)
Waechter R, Burgen KS, Punch B, Evans R, Blackmon K, Noel T, Fernandes M, Landon B. Improving neurodevelopment in Zika-exposed children: A randomized controlled trial. PLoS Negl Trop Dis. 2022 Mar 8;16(3):e0010263. doi: 10.1371/journal.pntd.0010263. eCollection 2022 Mar.
PMID: 35259172DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Randall Waechter, PhD
Windward Islands Research and Education Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Neurocognitive assessors are blinded to which participants have received the intervention during their longitudinal visits.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Director of Research
Study Record Dates
First Submitted
January 4, 2021
First Posted
January 6, 2021
Study Start
September 3, 2018
Primary Completion
February 22, 2020
Study Completion
February 28, 2020
Last Updated
January 7, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share